相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance
Minh Ngoc Duong et al.
ONCOTARGET (2017)
Signals from the Adipose Microenvironment and the Obesity-Cancer Link-A Systematic Review
Caroline Himbert et al.
CANCER PREVENTION RESEARCH (2017)
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients
Carmine Carbone et al.
CLINICAL CANCER RESEARCH (2017)
An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients
Geny Piro et al.
CLINICAL CANCER RESEARCH (2016)
Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy
Joao Incio et al.
CANCER DISCOVERY (2016)
Adipocytes WNT5a mediated dedifferentiation: a possible target in pancreatic cancer microenvironment
Elena Zoico et al.
ONCOTARGET (2016)
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients
G. Piro et al.
BRITISH JOURNAL OF CANCER (2015)
Ror2 as a Therapeutic Target in Cancer
Zufan Debebe et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Metastatic pancreatic cancer: Is there a light at the end of the tunnel?
Vanja Vaccaro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma
Jianfei Huang et al.
SCIENTIFIC REPORTS (2015)
Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi-directionally convert into cancer stem cells
Elisa Dalla Pozza et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
An Angiopoietin-like Protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis
Carmine Carbone et al.
ONCOTARGET (2015)
What We Talk About When We Talk About Fat
Evan D. Rosen et al.
CELL (2014)
Pancreatic Cancer: Systemic Combination Therapies for a Heterogeneous Disease
Davide Melisi et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
High-Fat, High-Calorie Diet Promotes Early Pancreatic Neoplasia in the Conditional KrasG12D Mouse Model
David W. Dawson et al.
CANCER PREVENTION RESEARCH (2013)
Rationale and clinical use of multitargeting anticancer agents
Davide Melisi et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Prediagnostic Body Mass Index and Pancreatic Cancer Survival
Chen Yuan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Biomarker analysis in the first-in-human phase 1a study for vantictumab (OMP-18R5; anti-Frizzled) demonstrates pharmacodynamic (PD) modulation of the Wnt pathway in patients with advanced solid tumors.
David C. Smith et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Comparative Study of Immune Regulatory Properties of Stem Cells Derived from Different Tissues
Mariano Di Trapani et al.
STEM CELLS AND DEVELOPMENT (2013)
Obesity and cancer risk: evidence, mechanisms, and recommendations
Ivana Vucenik et al.
NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Pancreatic Cancer: Between Bench and Bedside
Davide Melisi et al.
CURRENT DRUG TARGETS (2012)
Wnt5a-Ror-Dishevelled signaling constitutes a core developmental pathway that controls tissue morphogenesis
Hsin-Yi Henry Ho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Paracrine and Endocrine Effects of Adipose Tissue on Cancer Development and Progression
Jiyoung Park et al.
ENDOCRINE REVIEWS (2011)
Emerging pathways and future targets for the molecular therapy of pancreatic cancer
Vanja Vaccaro et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Nuclear localization of orphan receptor protein kinase (Ror1) is mediated through the juxtamembrane domain
Hsiao-Chun Tseng et al.
BMC CELL BIOLOGY (2010)
Subcutaneous adipose tissue classification
A. Sbarbati et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2010)
Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors
Luca Grumolato et al.
GENES & DEVELOPMENT (2010)
Oral Poly(ADP-Ribose) Polymerase-1 Inhibitor BSI-401 Has Antitumor Activity and Synergizes with Oxaliplatin against Pancreatic Cancer, Preventing Acute Neurotoxicity
Davide Melisi et al.
CLINICAL CANCER RESEARCH (2009)
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Andrew G. Renehan et al.
LANCET (2008)
Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Purified Wnt5a protein activates or inhibits β-catenin-TCF signaling depending on receptor context
AJ Mikels et al.
PLOS BIOLOGY (2006)
LS14: A novel human adipocyte cell line that produces prolactin
ER Hugo et al.
ENDOCRINOLOGY (2006)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Physical activity, obesity, height, and the risk of pancreatic cancer
DS Michaud et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
